Azzad Asset Management Inc. ADV Cuts Stake in National Research Co. (NASDAQ:NRC)

Azzad Asset Management Inc. ADV lessened its stake in National Research Co. (NASDAQ:NRC) by 18.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,481 shares of the company’s stock after selling 4,609 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in National Research were worth $470,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in National Research by 184.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock valued at $126,000 after acquiring an additional 2,061 shares during the last quarter. Gladius Capital Management LP grew its position in shares of National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after purchasing an additional 496 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in shares of National Research by 54.4% in the fourth quarter. Teacher Retirement System of Texas now owns 11,637 shares of the company’s stock worth $460,000 after purchasing an additional 4,102 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of National Research by 22.3% in the fourth quarter. BNP Paribas Financial Markets now owns 11,479 shares of the company’s stock worth $454,000 after buying an additional 2,095 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in National Research by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock valued at $25,176,000 after buying an additional 7,531 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Stock Performance

NASDAQ NRC opened at $22.80 on Friday. The stock has a market capitalization of $544.40 million, a PE ratio of 18.39 and a beta of 0.49. National Research Co. has a 1-year low of $20.41 and a 1-year high of $47.25. The business has a 50 day simple moving average of $22.95 and a two-hundred day simple moving average of $30.44. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.41 and a quick ratio of 0.41.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.26 earnings per share for the quarter. National Research had a net margin of 20.60% and a return on equity of 54.83%. The company had revenue of $35.02 million for the quarter.

National Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Friday, September 27th. National Research’s payout ratio is 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.